Lipid A--Target for Antibacterial Drugs
- 8 November 1996
- journal article
- review article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 274 (5289) , 939
- https://doi.org/10.1126/science.274.5289.939
Abstract
Bacteria are rapidly developing resistance to drugs, rendering treatment of some diseases difficult or impossible. A report by Onishi et al . in this issue ( p. 980 ) announces the discovery of a new drug directed at a never-before-assaulted part of the bacteria, the lipid A portion of the bacterial outer membrane. In his Perspective, Vaara discusses the worldwide problem of drug-resistant pathogenic bacteria and how this new agent exemplifies the tack we must now take to fight these diseases.This publication has 18 references indexed in Scilit:
- Antibacterial Agents That Inhibit Lipid A BiosynthesisScience, 1996
- Antibiotics That Resist ResistanceScience, 1995
- Balancing the drug-resistance equationTrends in Microbiology, 1994
- Multiple-Antibiotic-Resistant Pathogenic Bacteria -- A Report on the Rockefeller University WorkshopNew England Journal of Medicine, 1994
- Hospital-acquired infections: diseases with increasingly limited therapies.Proceedings of the National Academy of Sciences, 1994
- Epidemiology of Drug Resistance: Implications for a Post—Antimicrobial EraScience, 1992
- The lipid A biosynthesis mutation lpxA2 of Escherichia coli results in drastic antibiotic supersusceptibilityAntimicrobial Agents and Chemotherapy, 1992
- BIOCHEMISTRY OF ENDOTOXINSAnnual Review of Biochemistry, 1990
- A new class of synthetic antibacterials acting on lipopolysaccharide biosynthesisNature, 1987
- Sensitization of Gram-negative bacteria to antibiotics and complement by a nontoxic oligopeptideNature, 1983